Cargando…
T Cells and Adoptive Immunotherapy: Recent Developments and Future Prospects in Gastrointestinal Oncology
Gastrointestinal oncology is one of the foremost causes of death: the gastric cancer accounts for 10.4% of cancer deaths worldwide, the pancreatic cancer for 6%, and finally, the colorectal cancer for 9% of all cancer-related deaths. For all these gastrointestinal cancers, surgical tumor resection r...
Autores principales: | Amedei, Amedeo, Niccolai, Elena, D'Elios, Mario M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3216375/ https://www.ncbi.nlm.nih.gov/pubmed/22110523 http://dx.doi.org/10.1155/2011/320571 |
Ejemplares similares
-
What Is Recent in Pancreatic Cancer Immunotherapy?
por: Niccolai, Elena, et al.
Publicado: (2013) -
Novel Immunotherapeutic Strategies of Gastric Cancer Treatment
por: Amedei, Amedeo, et al.
Publicado: (2011) -
Skin CD30(+) T cells and circulating levels of soluble CD30 are increased in patients with graft versus host disease
por: Amedei, Amedeo, et al.
Publicado: (2013) -
Multiple Sclerosis: The Role of Cytokines in Pathogenesis and in Therapies
por: Amedei, Amedeo, et al.
Publicado: (2012) -
T Cells in Gastric Cancer: Friends or Foes
por: Amedei, Amedeo, et al.
Publicado: (2012)